Search

everythinglearnresearchcommunity

for

Search:↓

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Bald men may have a lower risk of testicular cancer.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

About half of Taiwanese dermatologists use dermoscopy, mainly to improve diagnosis and detect cancer early, but cost and lack of training limit its wider use.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

A woman's male-like physical changes were caused by two rare ovarian conditions.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

A woman's skin symptoms led to a diagnosis of systemic AL amyloidosis, but she died from sepsis shortly after.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.